| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017PLoSO..1270654T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0170654 |
| P932 | PMC publication ID | 5249163 |
| P698 | PubMed publication ID | 28107527 |
| P50 | author | Milica Bozic | Q41632660 |
| Jose M Valdivielso | Q41584735 | ||
| P2093 | author name string | David Goltzman | |
| Elvira Fernandez | |||
| Noelia Torremadé | |||
| P2860 | cites work | Vitamin D metabolites and/or analogs: which D for which patient? | Q55057211 |
| Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite | Q59089758 | ||
| Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges | Q61483893 | ||
| Stimulation of 24,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3 | Q69735796 | ||
| The effect of vitamin D on the absorption of inorganic phosphate | Q73602427 | ||
| High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro | Q77417313 | ||
| Vitamin D | Q78117743 | ||
| Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice | Q80441827 | ||
| 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D | Q85236547 | ||
| Differential effects of vitamin D analogs on vascular calcification | Q42163977 | ||
| Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins | Q42929298 | ||
| Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport | Q44007634 | ||
| Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats | Q44137817 | ||
| Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney. | Q44625383 | ||
| Differential regulation by 1,25-dihydroxyvitamin D3 of calbindin-D9k and calbindin-D28k gene expression in mouse kidney | Q44712858 | ||
| High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin | Q46160285 | ||
| K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease | Q46286369 | ||
| Recent developments in the management of secondary hyperparathyroidism | Q46477411 | ||
| Calcification of the coronary arteries in the absence of atherosclerotic plaque | Q46709072 | ||
| Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia | Q47978841 | ||
| Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1α-Hydroxylase Expression in Vascular Smooth Muscle Cells. | Q50226760 | ||
| The role of phosphorus in the development and progression of vascular calcification | Q26823897 | ||
| Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development | Q27320886 | ||
| Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption | Q28140902 | ||
| Calcification of the internal elastic lamina of coronary arteries | Q28282911 | ||
| Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells. | Q30500628 | ||
| Molecular mechanism of active Ca2+ reabsorption in the distal nephron | Q34112653 | ||
| KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). | Q34994912 | ||
| Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure | Q35841012 | ||
| Pathogenesis of vascular calcification in chronic kidney disease. | Q36192817 | ||
| Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses | Q36211599 | ||
| Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction | Q36312727 | ||
| Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins | Q36322457 | ||
| High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice | Q36909982 | ||
| Determinants of parathyroid hormone response to vitamin D supplementation: a systematic review and meta-analysis of randomised controlled trials | Q38580365 | ||
| The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells | Q40297845 | ||
| The promoter region of the human PMCA1 gene mediates transcriptional downregulation by 1,25-dihydroxyvitamin D(3). | Q40844755 | ||
| Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cells | Q40867880 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholecalciferol | Q139347 |
| chronic renal insufficiency | Q736715 | ||
| P304 | page(s) | e0170654 | |
| P577 | publication date | 2017-01-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase | |
| P478 | volume | 12 |
| Q48353581 | Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis | cites work | P2860 |
Search more.